You are here
Closed
NOTE: The Solicitations and topics listed on this site are copies from the various SBIR agency solicitations and are not necessarily the latest and most up-to-date. For this reason, you should visit the respective agency SBIR sites to read the official version of the solicitations and download the appropriate forms and rules.
-
DHA241-001: Psoralen-UV-A Irradiation Based High-throughput Pathogen Inactivation Device
Release Date: 11-29-2023Open Date: 01-03-2024Due Date: 02-21-2024Close Date: 02-21-2024OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Military Infectious Diseases OBJECTIVE: Develop and validate a high-throughput psoralen/ultraviolet A(UV-A) based pathogen inactivation device capable of inactivating pathogens at a wide range of volumes (from 0.01 L to 50 L). The solution can facilitate rapid development of vaccines against any emerging infectious threats to protect civilian and militar ...
SBIRPhase I/Phase IIDepartment of DefenseDefense Health Agency -
DHA241-002: Development of a Junctional Tourniquet
Release Date: 11-29-2023Open Date: 01-03-2024Due Date: 02-21-2024Close Date: 02-21-2024OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Combat Casualty Care OBJECTIVE: To rethink the form factor and engineering approach of existing junctional tourniquets, providing reliable control of junctional hemorrhage. Such a solution must be readily accessible at the point of injury and designed to be user-friendly and intuitive, enabling use by non-medical personnel for self-aid and buddy care sce ...
SBIRPhase I/Phase IIDepartment of DefenseDefense Health Agency -
DHA241-D001: Rapid Manufacturing of Personalized Braces and Splints for Musculoskeletal Injury
Release Date: 11-29-2023Open Date: 01-03-2024Due Date: 02-21-2024Close Date: 02-21-2024OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Military Operational Medicine OBJECTIVE: This topic is intended for technology proven ready to move directly into Phase II and is accepting Direct to Phase II proposals only. To develop a manufacturing framework to rapidly produce personalized, human-usable braces and splints with no-to-minimal manual intervention. The solution can accelerate musculoskel ...
SBIRPhase I/Phase IIDepartment of DefenseDefense Health Agency -
DHA241-D002: Wireless, Wearable Personal Metabolic Sensor
Release Date: 11-29-2023Open Date: 01-03-2024Due Date: 02-21-2024Close Date: 02-21-2024OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Military Operational Medicine OBJECTIVE: This topic is intended for technology proven ready to move directly into Phase II and is accepting Direct to Phase II proposals only. A low-cost sensor that accurately measures oxygen consumption (VO2) and carbon dioxide production (VCO2) and provides immediate feedback that Service Members can use to improve fitn ...
SBIRPhase I/Phase IIDepartment of DefenseDefense Health Agency -
DHA233-001: Rapid Diagnostic for Invasive Fungal Infection
Release Date: 08-23-2023Open Date: 09-20-2023Due Date: 10-18-2023Close Date: 10-18-2023OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Military Infectious Disease OBJECTIVE: Develop a technical solution or device for the identification of an Invasive Fungal Wound Infections in a Military Treatment Facility or lower Role of Care within 24 hours. DESCRIPTION: Trauma-related invasive fungal wound infections (IFIs) are associated with significant morbidity and mortality (8-12% mortality). Ear ...
SBIRPhase I/Phase IIDepartment of DefenseDefense Health Agency -
DHA233-002: Novel Fieldable Device for Detection of Sleep Microarousals
Release Date: 08-23-2023Open Date: 09-20-2023Due Date: 10-18-2023Close Date: 10-18-2023OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Military Operational Medicine OBJECTIVE: Develop a fieldable, wearable device that detects microarousals during sleep. DESCRIPTION: It is well known that Soldiers consistently fail to obtain the 7-9 hours of nightly sleep that is recommended by National Sleep Foundation (Watson et al., 2015). In fact, more than 62% of Soldiers average less than 6 hours of ...
SBIRPhase I/Phase IIDepartment of DefenseDefense Health Agency -
DHA233-003: Operator State Monitoring: Minimally Intrusive Monitoring of Peripheral and Cerebral Blood Oxygen as Well as Pulse and Respiratory Rates in Future Vertical Lift Aircrew
Release Date: 08-23-2023Open Date: 09-20-2023Due Date: 10-18-2023Close Date: 10-18-2023OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Military Operational Medicine OBJECTIVE: Develop and demonstrate nonintrusive technology to monitor cerebral blood oxygen, pulse oximetry, pulse rate, respiration rate, and possible impact trauma of Army aviators during flight. DESCRIPTION: The Army’s Future Vertical Lift (FVL) program, which includes SOCOM, is developing aircraft with dramatically expan ...
SBIRPhase I/Phase IIDepartment of DefenseDefense Health Agency -
DHA233-004: Technology to Drive 60-day Runtimes in Wearable Devices
Release Date: 08-23-2023Open Date: 09-20-2023Due Date: 10-18-2023Close Date: 10-18-2023OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Military Operational Medicine OBJECTIVE: Invent and/or develop hardware and embedded software technologies integrated onto a self-powered on-body sensor. The wearable device should include physiological and environmental sensing, recording, and processing that should operate off a non-AC/DC power supply. The device shall be capable of a minimum of 60-day ru ...
SBIRPhase I/Phase IIDepartment of DefenseDefense Health Agency -
DHA233-D001: Medical Oxygen Storage and Delivery for Deployed Joint Services’ Casualty Care
Release Date: 08-23-2023Open Date: 09-20-2023Due Date: 10-18-2023Close Date: 10-18-2023OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Combat Casualty Care OBJECTIVE: Develop a composite, or other, lightweight, low ballistic hazard oxygen cylinder/tank for medical grade oxygen in deployed environments. Meet/exceed D Cylinder volume; improve upon logistics by reducing weight and making cylinders self-stackable and interlocking. DESCRIPTION: The ability to store and deliver oxygen to patie ...
SBIRPhase I/Phase IIDepartment of DefenseDefense Health Agency -
DHA23C-001: Multi-faceted mAb Development Program for Multi-Drug Resistant Wound Infections
Release Date: 08-23-2023Open Date: 09-20-2023Due Date: 10-18-2023Close Date: 10-18-2023OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Military Infectious Disease OBJECTIVE: The objective of this topic would be to develop human monoclonal antibodies (mAbs) that have demonstrated efficacy and safety in a screening infected wound animal model against multi-drug resistant bacteria. DESCRIPTION: Multi-drug resistant (MDR) infections have caused significant morbidity and mortality for US Servi ...
STTRPhase IDepartment of DefenseDefense Health Agency